drugset / Trial / NCT06569953
Efficacy and Safety of Liposomal Bupivacaine Injection for Paravertebral Nerve Block in the Treatment of Acute and Chronic Pain After Thoracoscopic Pneumonectomy: A Multicenter, Randomized, Double-blind, Controlled Clinical Trial
Phase 4
Recruiting
284 enrolled
The Second Affiliated Hospital of Chongqing Medical University
LanZhou University · collabPeople's Hospital of Chongqing · collabShapingba District People's Hospital of Chongqing · collabXiangya Hospital of Central South University · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The goal of this clinical trial is to evaluate the efficacy and safety of liposomal Bupivacaine administered by paravertebral block for the treatment of acute and chronic pain after video-assisted thoracoscopic lobectomy.
Timeline
- Start
- 2024-08-26
- Primary completion
- 2025-08-31
- Completion
- 2025-08-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupivacaine | Other / unclassified | 100 mg | Other |
| Subject | Bupivacaine | Other / unclassified | 266 mg | Other |